For a child who has undergone surgical excision of an affected lymph node, what antimicrobial regimen (including specific drug, dose, and duration) should be given if the excision is incomplete or residual disease is suspected?

Treatment After Surgical Excision of NTM Lymphadenitis in Children

For children who have undergone complete surgical excision of nontuberculous mycobacterial (NTM) cervical lymphadenitis, no antimicrobial therapy is needed; however, if excision is incomplete or residual disease is suspected, treat with clarithromycin-based multidrug therapy using the same regimen as for MAC pulmonary disease for 6-12 months. 1

Primary Recommendation: Complete Excision

The ATS/IDSA guidelines are unequivocal that excisional surgery without chemotherapy is the recommended treatment for children with NTM cervical lymphadenitis, with a 95% success rate 1. This is supported by high-quality randomized controlled trial data showing surgical excision achieves 96% cure rates compared to only 66% with antibiotics alone 2.

When to Add Antimicrobial Therapy

Antimicrobial therapy should be considered in these specific scenarios:

Recurrent Disease or Incomplete Excision

• Regimen: Clarithromycin-based multidrug regimen (same as used for MAC pulmonary disease)
• Duration: 6-12 months 1
• Rationale: The guidelines explicitly state this approach for recurrent disease or when surgical risk is high 1

Specific Drug Regimen Details

While the ATS/IDSA guidelines reference "clarithromycin multidrug regimen such as that used for pulmonary disease," the specific components typically include:

• Clarithromycin (macrolide backbone)
• Plus rifabutin (based on the RCT that used clarithromycin + rifabutin for ≥12 weeks) 2
• Consider ethambutol as third agent for more extensive disease

Important caveat: The guidelines note that "experience with such an approach is limited" but support it based on clarithromycin's proven activity against MAC in other clinical settings 1.

Critical Pitfalls to Avoid

What NOT to Do:

• Never use anti-TB drugs alone without a macrolide - this has been associated with persistent disease, sinus tract formation, and chronic drainage 1
• Avoid incisional biopsy alone as definitive treatment - this frequently leads to treatment failure 1

Special Consideration: Strongly Positive PPD

If the child has a strongly positive tuberculin skin test (e.g., ≥15 mm) with granulomatous disease:

• Start anti-TB therapy while awaiting culture results
• Especially important if TB risk factors present (positive family history, foreign-born)
• Discontinue anti-TB therapy if cultures negative for mycobacteria (unless significant TB risk factors persist) 1

Evidence Quality and Nuances

The recommendation for surgery alone is based on Level A evidence from the authoritative ATS/IDSA statement 1 and confirmed by a multicenter RCT 2. Notably, one study of M. abscessus osteomyelitis showed resolution even without antibiotics when surgical debridement was complete 3, reinforcing that adequate surgery may be sufficient as sole therapy.

However, the antibiotic regimen for incomplete excision is based on extrapolation from pulmonary disease treatment rather than specific pediatric lymphadenitis trials, representing a weaker evidence base for this specific scenario 1.

Practical Algorithm

1. If complete excision achieved → No antibiotics needed, observe
2. If incomplete excision or residual disease → Clarithromycin + rifabutin (± ethambutol) for 6-12 months
3. If recurrence after initial complete excision → Repeat surgical excision preferred; antibiotics as alternative
4. If high surgical risk (e.g., facial nerve involvement) → Consider antibiotics as primary therapy